Too high: Older drugs work well for hypertension, new medications show little innovation

This lack of innovation from drug companies is concerning given the huge burden of disease caused by inadequately treated high blood pressure. For now, the older drugs are the best drugs, but very often must be combined with each other.

This is second piece in a five-part series on “too high” blood pressure, created for those with high blood pressure and their family and friends. Future articles will discuss drug side effects, the power of lifestyle changes, and appropriate blood pressure targets. Some data in this series come from QuintilesIMS. For additional information, please contact rstaff@stanford.edu.

Randall Stafford, MD, PhD, a professor of medicine and director of the Program on Prevention Outcomes and Practices, practices primary care internal medicine at Stanford. He is developing practical strategies to improve how physicians and consumers approach chronic disease treatment and prevention.

Leave a Reply

Your email address will not be published. Required fields are marked *